<bill session="115" type="h" number="5927" updated="2019-07-16T21:20:07Z">
  <state datetime="2018-05-23">REFERRED</state>
  <status>
    <introduced datetime="2018-05-23"/>
  </status>
  <introduced datetime="2018-05-23"/>
  <titles>
    <title type="official" as="introduced">To amend the Public Health Service Act to expand, intensify, and coordinate research and other activities of the National Institutes of Health with respect to prenatal opioid exposure and neonatal abstinence syndrome.</title>
    <title type="short" as="introduced">Neonatal Abstinence Syndrome Best Practice Act</title>
    <title type="short" as="introduced">Neonatal Abstinence Syndrome Best Practice Act</title>
    <title type="display">Neonatal Abstinence Syndrome Best Practice Act</title>
  </titles>
  <sponsor bioguide_id="S001200"/>
  <cosponsors>
    <cosponsor bioguide_id="F000466" joined="2018-05-23"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-23" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health promotion and preventive care"/>
    <term name="Home and outpatient care"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Research administration and funding"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary date="2018-05-23T04:00:00Z" status="Introduced in House">Neonatal Abstinence Syndrome Best Practice Act

This bill amends the Public Health Service Act to require the National Institutes of Health to: (1) expand research regarding prenatal opioid exposure and neonatal abstinence syndrome, and (2) establish best practices for screening and treatment.</summary>
  <committee-reports/>
</bill>
